Scott Rocklage Combines Knowledge and Experience to Create Disruptive Medical Companies

Scott Rocklage is nothing short of a mover and shaker in the investment industry. Rocklage has a Ph.D. and is presently a managing partner at 5AM Ventures. Along with an impressive education, he brings over 30 years of experience to the task each day.

His management experience, coupled with his healthcare background, makes him a most formidable business executive. As siuch, the FDA has approved three new drug applications that include Omniscan, Cubicin, and Teslascan. Learn more about Scott Rocklage:

His leadership abilities are a major reason he could obtain FDA approval. His impressive management background also includes President and CEO of Nycomed Salutar, CEO of Cubist Pharmaceuticals, and President of Nycomed Salutar.

He is both revered in the world of venture capital and healthcare. His company has offices in San Francisco, California, and Waltham, Massachusetts.

Rocklage received a BS degree in Chemistry from the University of California, Berkley. He received his Ph.D. in Chemistry from MIT and studied under the famed Nobel Prize winner, Richard R. Schrock. 5AM Ventures, today, ranks as one of the world’s premier venture capital companies that focuses on life sciences.

The company also supports business entities that are striving to develop solutions that will solve healthcare needs. These companies include those that develop nontraditional approaches to diagnose and treat an array of medical conditions. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn

Everyone on Scott Rocklage’s team has an area of expertise in one of the following: business, medical, finance, legal, medical, or scientific. Rocklage takes a hands-on approach when building his businesses. He also provides a great deal of investment dollars out of his own pocket.

Leave a Reply

Recent Posts